Raltegravir

• Description :

  A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.

• Stability :

  ≥ 2 years

• Purity :

  >98% (HPLC)

• Weight :

  444.4164

• Molecular Formula :

  C20H21FN6O5

• Notes :

  Research use only, not for human use.

• Receptor :

  Integrase (S217QPFV) |Integrase (WTPFV)

• CAS Number :

  518048-05-0